IGWM
GTHX

ICA Group Wealth Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

ICA Group Wealth Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$153 – 1431
2023
Q4 		$153 Buy
+50
New +$94 ﹤0.01% 1317
2023
Q3 		– Sell
-50
Closed -$125 – 1299
2023
Q2 		$125 Hold
50
– – ﹤0.01% 1309
2023
Q1 		$134 Buy
+50
New +$240 ﹤0.01% 1249

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ICA Group Wealth Management's GTHX Position: Q1 2024 in Review

ICA Group Wealth Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 50 shares — an estimated $153 sold.

ICA Group Wealth Management first reported a position in GTHX in Q1 2023 and held it in 3 quarters. The position peaked at $153 in Q4 2023. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

  • ICA Group Wealth Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 50 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $153.
  • ICA Group Wealth Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • ICA Group Wealth Management's G1 Therapeutics, Inc. Common Stock position peaked at $153 in Q4 2023.
  • 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on ICA Group Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.